.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Poster

PP11.02
Eposter presentation

Deciphering the enigma of atypical forms of Alzheimer's disease by employing connectomics in the context of early and late-phase Amyloid PET and [18F]FDG PET Imaging

Presented in

Diagnostic and therapeutic nuclear medicine I

Poster topics

Artificial intelligence

Diagnostic and therapeutic nuclear medicine

Authors

Dr. Alessio Cirone (Genoa / IT), Wendy Kreshpa (Genoa / IT), Sara Garbarino (Genoa / IT), Federico Massa (Genoa / IT), Stefano Raffa (Genoa / IT), Gianmario Sambuceti (Genoa / IT), Michele Piana (Genoa / IT), Andrea Chincarini (Genoa / IT), Luca Roccatagliata (Genoa / IT), Antonio Uccelli (Genoa / IT), Silvia Morbelli (Genoa / IT; Turin / IT), Matteo Pardini (Genoa / IT)